News Bluebird Bio Announces Public Offering Bluebird Bio, a biotech company based in Somerville, Massachusetts, has announced a public offering of over 83.3 million shares at a price of ... By fxcoach20th December 20230
News BlueBird Bio Shares Soar 53.30% After FDA’s Committee Approves its Beti-cel Gene Therapy Bluebird Bio Stock surges nearly 53% after an advisory committee to the U.S. Food and Drug Administration votes to approve beti-cel gene therapy ... By fxcoach13th June 20220